These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23902796)

  • 1. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
    Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
    BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
    Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
    Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J; Shang Y; Liu S; Piao Y; Cui X; Li Y; Lin Z
    Diagn Pathol; 2014 Mar; 9():67. PubMed ID: 24650035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
    Martinez-Useros J; Rodriguez-Remirez M; Borrero-Palacios A; Moreno I; Cebrian A; Gomez del Pulgar T; del Puerto-Nevado L; Vega-Bravo R; Puime-Otin A; Perez N; Zazo S; Senin C; Fernandez-Aceñero MJ; Soengas MS; Rojo F; Garcia-Foncillas J
    BMC Cancer; 2014 Dec; 14():965. PubMed ID: 25515240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer.
    Cai J; Ma H; Huang F; Zhu D; Zhao L; Yang Y; Bi J; Zhang T
    Int J Clin Exp Pathol; 2014; 7(8):4959-70. PubMed ID: 25197367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
    Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.
    Ou Y; Xia R; Kong F; Zhang X; Yu S; Jiang L; Zheng L; Lin L
    Oncol Lett; 2016 Mar; 11(3):1823-1828. PubMed ID: 26998084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
    Zhu J; Chen X; Liao Z; He C; Hu X
    Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
    Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
    Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
    Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
    PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEK: A novel early screening and prognostic marker for breast cancer.
    Ying G; Wu Y
    Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J
    BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
    Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
    Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of high NQO1 expression in breast cancers.
    Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L
    J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between DEK oncogene expression and oral squamous cell carcinoma].
    Wang X; Huang SH; Yu LQ; Liu J; Diao Y; Sun CF
    Shanghai Kou Qiang Yi Xue; 2014 Feb; 23(1):75-9. PubMed ID: 24608617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
    Lin LJ; Chen LT
    Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MSP58 in human colorectal cancer and its correlation with prognosis.
    Shi H; Li SJ; Zhang B; Liu HL; Chen CS
    Med Oncol; 2012 Dec; 29(5):3136-42. PubMed ID: 22773039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.